PLUR · Pluri Inc.
$1.58
-0.10 (-5.95%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“According to our management's estimates, we have sufficient resources to meet our operating obligations for a period of less than three months from the issuance date of our interim unaudited condensed consolidated financial statements, which was May 14, 2026. These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$17.05M
Shares
10.79M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.34M
+309.8%
FY2025
Net Income
-$22.58M
-8.1%
FY2025
Gross Margin
48.95%
-49.8pp
FY2025
Operating Margin
-1659.88%
+5137pp
FY2025
Diluted EPS
-$3.56
+10.8%
FY2025
Operating Cash Flow
-$18.21M
-1.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.08M | $1.34M | $326K | $287K | $234K | — | $23K | $54K | $50K | — | $2.85M | $379K | $379K | $679K | $716K | — | — | |
| $615K | $682K | $4000 | $9000 | — | — | — | $2000 | $2000 | — | $100K | $13K | $11K | $20K | $21K | — | — | |
| $464K | $654K | $322K | $278K | $234K | — | $23K | $52K | $48K | — | $2.75M | $366K | $368K | $659K | $695K | — | — | |
| — | 48.95% | 98.77% | 96.86% | 100% | — | 100% | 96.3% | 96% | — | 96.49% | 96.57% | 97.1% | 97.05% | 97.07% | — | — | |
| $15.71M | $12.85M | $12.45M | $15.75M | $24.61M | $30.53M | $23.1M | $29.88M | $26.37M | $24M | $22.86M | $23.42M | $24.94M | $19.91M | $12.69M | $8.31M | $6.12M | |
| $10.76M | $9.98M | $10.03M | $11.78M | $17.45M | $20.56M | $7.92M | $9.16M | $11.19M | $6.93M | $6.49M | $6.46M | $8.68M | $5.65M | $6.57M | $4.49M | $3.14M | |
| $498K | $316K | $253K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$26.01M | -$22.18M | -$22.16M | -$27.25M | -$41.59M | -$50.62M | -$29.48M | -$35.53M | -$33.73M | -$28.02M | -$23.32M | -$25.27M | -$27.85M | -$22.22M | -$15.03M | -$11.11M | -$7.44M | |
| — | -1659.88% | -6796.93% | -9493.38% | -17774.79% | — | -128156.52% | -65800% | -67462% | — | -819.07% | -6666.75% | -7348.28% | -3272.9% | -2099.3% | — | — | |
| -$25.52M | -$21.86M | -$21.91M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $930K | $873K | $866K | $843K | $887K | $78K | — | — | — | — | — | — | — | — | — | — | — | |
| $727K | $1.14M | $1.41M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$961K | -$1.08M | $814K | -$1.64M | $219K | $758K | $324K | $225K | $7.61M | $205K | $73K | $590K | $918K | $1.07M | $237K | — | — | |
| -$26.97M | -$23.26M | -$21.34M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$5000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$25.54M | -$22.58M | -$20.89M | -$28.32M | -$41.24M | -$49.87M | -$29.15M | -$35.31M | -$26.13M | -$27.81M | -$23.25M | -$24.68M | -$26.93M | -$21.16M | -$14.79M | -$10.85M | -$7.45M | |
| — | -1690.34% | -6407.36% | -9867.94% | -17624.79% | — | -126747.83% | -65383.33% | -52252% | — | -816.51% | -6511.08% | -7106.07% | -3115.61% | -2066.2% | — | — | |
| -$1.41M | -$667K | -$456K | -$566K | -$132K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $15.81B | $6.33B | $5.24B | $28.89M | $41.37M | $49.87M | $29.15M | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$29.15M | -$35.31M | -$28.13M | -$27.3M | -$23.91M | -$25.5M | -$24.23M | -$20.77M | -$14.92M | -$10.85M | — | |
| USD/shares | — | -$3.56 | -$3.99 | -$6.24 | -$10.24 | -$14.16 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$3.56 | -$3.99 | -$6.24 | -$10.24 | -$14.16 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 6.34M | 5.24M | 4.58M | 4.02M | 3.51M | 2.27M | 1.54M | 1.32M | 1.09M | 9.94M | 8.79M | 7.94M | 6.94M | 5.5M | — | — |
| shares | — | 6.34M | 5.24M | 4.58M | 4.02M | 3.51M | 2.27M | 1.54M | 1.32M | 1.09M | 9.94M | 8.79M | 7.94M | 6.94M | 5.5M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 19.47×
EV/EBIT
—
P/E (TTM)
—
Peer median 0.10×
Peer medians compare against the 232 similar-size Biotechnology companies (of 522 listed).